WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Axel Schönthal
100 Points

Contributions by role

Editor 100

Contributions by subject area

Hematology
Oncology
Otorhinolaryngology
Pathology
Medical Genetics

Axel H. Schönthal


Summary

Axel H. Schönthal, PhD, is an Associate Professor in the Department of Molecular Microbiology and Immunology at the Keck School of Medicine at the University of Southern California (USC) in Los Angeles. He received his PhD at the University of Karlsruhe, Germany, based on the study of oncogenes. This was followed by a postdoc in the area of molecular and cellular cancer biology at the University of California San Diego. Thereafter, he joined USC as a faculty member.

Dr. Schönthal’s current research uses preclinical and translational models to pursue the development of novel agents and novel delivery methods toward improved cancer therapeutic regimens, in particular for cancer types that originate in the brain or migrate there from systemic origins. As of 2021, he has authored and coauthored 180 scholarly articles with an H-Index of 50.

Molecular Biology Oncology

Past or current institution affiliations

University of Southern California

Work details

Associate Professor

University of Southern California
November 1992
Molecular Microbiology & Immunology
Preclinical research in molecular/cellular cancer biology, in vivo tumor models, anticancer drug development, and novel drug delivery methods.

Websites

  • PubMed Search

PeerJ Contributions

  • Edited 1

Academic Editor on

April 19, 2022
Serum expression of Vascular Endothelial-Cadherin, CD44, Human High mobility group B1, Kallikrein 6 proteins in different stages of laryngeal intraepithelial lesions and early glottis cancer
Michał Żurek, Anna Rzepakowska, Iwona Kotuła, Urszula Demkow, Kazimierz Niemczyk
https://doi.org/10.7717/peerj.13104 PubMed 35462765